Cargando…

Pathophysiology of Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus (T2DM), one of the most common metabolic disorders, is caused by a combination of two primary factors: defective insulin secretion by pancreatic β-cells and the inability of insulin-sensitive tissues to respond appropriately to insulin. Because insulin release and activity a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Galicia-Garcia, Unai, Benito-Vicente, Asier, Jebari, Shifa, Larrea-Sebal, Asier, Siddiqi, Haziq, Uribe, Kepa B., Ostolaza, Helena, Martín, César
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503727/ https://www.ncbi.nlm.nih.gov/pubmed/32872570 http://dx.doi.org/10.3390/ijms21176275

Ejemplares similares

Statin Treatment-Induced Development of Type 2 Diabetes: From Clinical Evidence to Mechanistic Insights
por: Galicia-Garcia, Unai, et al.
Publicado: (2020)

Cholesterol Efflux Efficiency of Reconstituted HDL Is Affected by Nanoparticle Lipid Composition
por: Jebari-Benslaiman, Shifa, et al.
Publicado: (2020)

Mutation type classification and pathogenicity assignment of sixteen missense variants located in the EGF-precursor homology domain of the LDLR
por: Galicia-Garcia, Unai, et al.
Publicado: (2020)

Pathophysiology of Atherosclerosis
por: Jebari-Benslaiman, Shifa, et al.
Publicado: (2022)

Validation of LDLr Activity as a Tool to Improve Genetic Diagnosis of Familial Hypercholesterolemia: A Retrospective on Functional Characterization of LDLr Variants
por: Benito-Vicente, Asier, et al.
Publicado: (2018)

Familial Hypercholesterolemia: The Most Frequent Cholesterol Metabolism Disorder Caused Disease
por: Benito-Vicente, Asier, et al.
Publicado: (2018)

Predictive Modeling and Structure Analysis of Genetic Variants in Familial Hypercholesterolemia: Implications for Diagnosis and Protein Interaction Studies
por: Larrea-Sebal, Asier, et al.
Publicado: (2023)

MLb-LDLr: A Machine Learning Model for Predicting the Pathogenicity of LDLr Missense Variants
por: Larrea-Sebal, Asier, et al.
Publicado: (2021)

Cardiovascular Disease, Atherosclerosis and Familial Hypercholesterolemia: From Molecular Mechanisms Causing Pathogenicity to New Therapeutic Approaches
por: Jebari-Benslaiman, Shifa, et al.
Publicado: (2023)

A Systematic Approach to Assess the Activity and Classification of PCSK9 Variants
por: Uribe, Kepa B., et al.
Publicado: (2021)

p.(Asp47Asn) and p.(Thr62Met): non deleterious LDL receptor missense variants functionally characterized in vitro
por: Benito-Vicente, A., et al.
Publicado: (2018)

Functional Characterization of p.(Arg160Gln) PCSK9 Variant Accidentally Found in a Hypercholesterolemic Subject
por: Larrea-Sebal, Asier, et al.
Publicado: (2023)

Replacement of cysteine at position 46 in the first cysteine-rich repeat of the LDL receptor impairs apolipoprotein recognition
por: Benito-Vicente, A., et al.
Publicado: (2018)

miR-27b Modulates Insulin Signaling in Hepatocytes by Regulating Insulin Receptor Expression
por: Benito-Vicente, Asier, et al.
Publicado: (2020)

Understanding the Mechanism of Translocation of Adenylate Cyclase Toxin across Biological Membranes
por: Ostolaza, Helena, et al.
Publicado: (2017)

Advantages and Versatility of Fluorescence-Based Methodology to Characterize the Functionality of LDLR and Class Mutation Assignment
por: Etxebarria, Aitor, et al.
Publicado: (2014)

Adenylate Cyclase Toxin promotes bacterial internalisation into non phagocytic cells
por: Martín, César, et al.
Publicado: (2015)

Calpain-Mediated Processing of Adenylate Cyclase Toxin Generates a Cytosolic Soluble Catalytically Active N-Terminal Domain
por: Uribe, Kepa B., et al.
Publicado: (2013)

Membrane Repair Mechanisms against Permeabilization by Pore-Forming Toxins
por: Etxaniz, Asier, et al.
Publicado: (2018)

Adenylate Cyclase Toxin Promotes Internalisation of Integrins and Raft Components and Decreases Macrophage Adhesion Capacity
por: Martín, César, et al.
Publicado: (2011)

Structural changes induced by acidic pH in human apolipoprotein B-100
por: Fernández-Higuero, José A., et al.
Publicado: (2016)

Cholesterol stimulates the lytic activity of Adenylate Cyclase Toxin on lipid membranes by promoting toxin oligomerization and formation of pores with a greater effective size
por: González Bullón, David, et al.
Publicado: (2021)

Identification and in vitro characterization of two new PCSK9 Gain of Function variants found in patients with Familial Hypercholesterolemia
por: Di Taranto, Maria Donata, et al.
Publicado: (2017)

Ca(2+) Influx and Tyrosine Kinases Trigger Bordetella Adenylate Cyclase Toxin (ACT) Endocytosis. Cell Physiology and Expression of the CD11b/CD18 Integrin Major Determinants of the Entry Route
por: Uribe, Kepa B., et al.
Publicado: (2013)

Membrane Permeabilization by Pore-Forming RTX Toxins: What Kind of Lesions Do These Toxins Form?
por: Ostolaza, Helena, et al.
Publicado: (2019)

Membrane Permeabilization by Bordetella Adenylate Cyclase Toxin Involves Pores of Tunable Size
por: González-Bullón, David, et al.
Publicado: (2019)

Age, Origin and Functional Study of the Prevalent LDLR Mutation Causing Familial Hypercholesterolaemia in Gran Canaria
por: Suárez, Nicolás M., et al.
Publicado: (2023)

Functional Analysis of LDLR (Low-Density Lipoprotein Receptor) Variants in Patient Lymphocytes to Assess the Effect of Evinacumab in Homozygous Familial Hypercholesterolemia Patients With a Spectrum of LDLR Activity
por: Banerjee, Poulabi, et al.
Publicado: (2019)

Pathophysiology of Diabetes Mellitus
por: Palicka, Vladimir
Publicado: (2002)

Type 2 diabetes mellitus in the pathophysiology of Alzheimer's disease
por: de Nazareth, Aparecida Marcelino
Publicado: (2017)

Type 2 Diabetes Mellitus: A Pathophysiologic Perspective
por: Westman, Eric C.
Publicado: (2021)

Pathophysiological Perspective of Osteoarthritis
por: Yunus, Mohd Heikal Mohd, et al.
Publicado: (2020)

Intelligent transport systems: technologies and applications
por: Perallos, Asier, et al.
Publicado: (2015)

The Pathophysiology of Gestational Diabetes Mellitus
por: Plows, Jasmine F, et al.
Publicado: (2018)

Pathophysiology and Management of Type 2 Diabetes Mellitus Bone Fragility
por: Eller-Vainicher, C., et al.
Publicado: (2020)

Genetics and pathophysiology of neonatal diabetes mellitus
por: Naylor, Rochelle N, et al.
Publicado: (2011)

Type 1 Diabetes Mellitus: Cellular and Molecular Pathophysiology at A Glance
por: Saberzadeh-Ardestani, Bahar, et al.
Publicado: (2018)

Alzheimer’s disease and type 2 diabetes mellitus: Pathophysiologic and pharmacotherapeutics links
por: Rojas, Milagros, et al.
Publicado: (2021)

Inflammatory and Other Biomarkers: Role in Pathophysiology and Prediction of Gestational Diabetes Mellitus
por: Abell, Sally K., et al.
Publicado: (2015)

A New Metabolomic Signature in Type-2 Diabetes Mellitus and Its Pathophysiology
por: Padberg, Inken, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_e2f54nm7ivd24ei0st8ij2h76r